Recently, you may have received a letter from Anthem explaining that your TriHealth physician was Out of Network. Unfortunately, Anthem sent this letter in error and is working to correct as soon as possible. For now, we want to confirm that your TriHealth provider is still In-Network with your Anthem insurance. Please do not cancel any appointments or start searching for a new physician without consulting your insurance first.
We apologize for any inconvenience this may have caused. We value you and are grateful for the trust you place in our TriHealth team to care for you and your family!
Composed of a team of research nurses and clinical research assistants, the TriHealth Hatton Research Institute's Oncology research team has many decades of experience in oncology research.
Clinical trials supported by our Oncology research team include cooperative group trials sponsored by the National Cancer Institute, studies through the Catholic Health Initiative, and Pharmaceutical Trials.
The term clinical trial is often raised in a hospital setting. It is likely that you will learn about possible clinical trials as you learn more about treatment options. Clinical trials occur in a secure and safe environment.
Clinical trials are experiments done in clinical research. Biomedical or behavioral research studies are designed to answer specific questions about new disease treatments (such as novel vaccines, drugs, dietary choices, dietary supplements and medical devices) and known interventions that warrant further study and comparison, but are not available for wide-spread use. This means that we are able to offer you options that may be new and cutting edge. Participating in a clinical trial it is ultimately your personal choice; however, clinical trials are conducted only after they have received health authority/ethics committee approval.
The TriHealth Hatton Research Institute's Oncology research team, and researchers at TriHealth’s Cancer Institute conduct important clinical trials targeting improvements in the prevention and treatment of specific kinds of cancer.
We screen ALL patients to determine who qualifies for clinical trials. Historically about fiver percent of our patients have qualified for trials.